René Imwinkelried
Director Ejecutivo en Siegfried Hameln Real Estate GmbH & Co. KG .
Cargos activos de René Imwinkelried
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Siegfried Hameln Real Estate GmbH & Co. KG
 Siegfried Hameln Real Estate GmbH & Co. KG Real Estate DevelopmentFinance Part of Siegfried Holding AG, Siegfried Hameln Real Estate GmbH & Co. KG provides real estate services. The company is based in Hameln, Germany. The CEOs of the German company are Arnoud Michael Middel, René Imwinkelried. | Director Ejecutivo | - | - |
Siegfried PharmaChemikalien Minden GmbH
 Siegfried PharmaChemikalien Minden GmbH Chemicals: SpecialtyProcess Industries Part of Siegfried Holding AG, Siegfried PharmaChemikalien Minden GmbH produces pharmaceutical ingredients. The company is based in Minden, Germany. The CEOs of the German company are Marco Millies, René Imwinkelried. | Director Ejecutivo | - | - |
Historial de carrera de René Imwinkelried
Antiguos cargos conocidos de René Imwinkelried.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SIEGFRIED HOLDING AG | Director de Operaciones | - | 31/12/2020 |
| Director Técnico/Científico/I+D | 01/09/2012 | - | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01/01/2010 | 01/09/2012 |
Lonza AG
 Lonza AG BiotechnologyHealth Technology Lonza AG engages in the research in as well as development, production, and distribution of chemical products and materials. The firm also carries out investment and lending transactions. The company was founded on December 7, 1897 and is headquartered in Visp, Switzerland. | Corporate Officer/Principal | 01/01/1991 | 01/01/2004 |
Schering-Plough Ltd.
 Schering-Plough Ltd. Pharmaceuticals: MajorHealth Technology Schering-Plough Ltd. manufactures and distributes pharmaceutical products. Its products include medicines for vascular diseases, oncology, opioid tendency, sexual health and virology. The company was founded on December 31, 1884 and is headquartered in Walton, the United Kingdom. | Corporate Officer/Principal | - | - |
Formación de René Imwinkelried.
| Swiss Federal Institute of Technology | Doctorate Degree |
Estadísticas
Internacional
| Suiza | 5 |
| Alemania | 3 |
| Reino Unido | 2 |
Operativa
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 2 |
| Chief Operating Officer | 1 |
Sectorial
| Health Technology | 4 |
| Finance | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SIEGFRIED HOLDING AG | Health Technology |
| Empresas privadas | 5 |
|---|---|
Schering-Plough Ltd.
Schering-Plough Ltd. Pharmaceuticals: MajorHealth Technology Schering-Plough Ltd. manufactures and distributes pharmaceutical products. Its products include medicines for vascular diseases, oncology, opioid tendency, sexual health and virology. The company was founded on December 31, 1884 and is headquartered in Walton, the United Kingdom. | Health Technology |
Siegfried Hameln Real Estate GmbH & Co. KG
Siegfried Hameln Real Estate GmbH & Co. KG Real Estate DevelopmentFinance Part of Siegfried Holding AG, Siegfried Hameln Real Estate GmbH & Co. KG provides real estate services. The company is based in Hameln, Germany. The CEOs of the German company are Arnoud Michael Middel, René Imwinkelried. | Finance |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Finance |
Lonza AG
Lonza AG BiotechnologyHealth Technology Lonza AG engages in the research in as well as development, production, and distribution of chemical products and materials. The firm also carries out investment and lending transactions. The company was founded on December 7, 1897 and is headquartered in Visp, Switzerland. | Health Technology |
Siegfried PharmaChemikalien Minden GmbH
Siegfried PharmaChemikalien Minden GmbH Chemicals: SpecialtyProcess Industries Part of Siegfried Holding AG, Siegfried PharmaChemikalien Minden GmbH produces pharmaceutical ingredients. The company is based in Minden, Germany. The CEOs of the German company are Marco Millies, René Imwinkelried. | Process Industries |
- Bolsa de valores
- Insiders
- René Imwinkelried
- Experiencia